Wedge Therapeutics

NEW MTA ORAL AIRWAYS ARE POISED TO TAKE OVER THE WORLDWIDE MARKET BECAUSE CURRENT ORAL AIRWAYS ARE DEFECTIVE

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location St Paul, MN, USA
  • Currency USD
  • Founded August 2013
  • Employees 3
  • Incorporation Type LLC
  • Website wedgetherapeutics.com

Company Summary

Oral (Oropharyngeal) Airways are used over 400 million times a year but have been clinically proven to be defective. That's why we have designed a new universal oral airway to take over the market and it works across the clinical spectrum:
- Mask Ventilation
- Endotracheal Tube Procedures
- Fiberoptic Procedures.

Our new patented Mandibular Thrust Airways (MTAs) will allow us to disrupt and take over a $350 million/year worldwide market.

Team

  • Robert Wieden
    President & CEO

    32 years of executive management experience, with a direct focus on developing business strategies and market plans to guide new products and services to market. He is a growth-oriented business builder that has led the development efforts for a plethora of “idea” stage technologies and new business enterprises. In that regard, he has led start-up/spin-off ventures for Fortune 500 technology firms, ACS, GTE, Storagetek and Perot Systems.

Advisors

  • Dr. T. Shantha
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free